BR0015024A - Aplicação de carbinóis substituìdos por 2-imidazolila para a preparação de um medicamento para o tratamento ou profilaxia de doenças provocadas por estados isquêmicos - Google Patents

Aplicação de carbinóis substituìdos por 2-imidazolila para a preparação de um medicamento para o tratamento ou profilaxia de doenças provocadas por estados isquêmicos

Info

Publication number
BR0015024A
BR0015024A BR0015024-0A BR0015024A BR0015024A BR 0015024 A BR0015024 A BR 0015024A BR 0015024 A BR0015024 A BR 0015024A BR 0015024 A BR0015024 A BR 0015024A
Authority
BR
Brazil
Prior art keywords
prophylaxis
preparation
medicine
treatment
application
Prior art date
Application number
BR0015024-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Andreas Weichert
Udo Labus
Has-Willi Jansen
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of BR0015024A publication Critical patent/BR0015024A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR0015024-0A 1999-10-27 2000-10-14 Aplicação de carbinóis substituìdos por 2-imidazolila para a preparação de um medicamento para o tratamento ou profilaxia de doenças provocadas por estados isquêmicos BR0015024A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19951701A DE19951701A1 (de) 1999-10-27 1999-10-27 Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten
PCT/EP2000/010126 WO2001030327A2 (de) 1999-10-27 2000-10-14 Verwendung von 2-imidazolyl-substituierten carbinolen zur herstellung eines medikaments zur behandlung oder prophylaxe von durch ischämischen zuständen

Publications (1)

Publication Number Publication Date
BR0015024A true BR0015024A (pt) 2002-06-18

Family

ID=7927020

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0015024-0A BR0015024A (pt) 1999-10-27 2000-10-14 Aplicação de carbinóis substituìdos por 2-imidazolila para a preparação de um medicamento para o tratamento ou profilaxia de doenças provocadas por estados isquêmicos

Country Status (30)

Country Link
US (1) US6291502B1 (cg-RX-API-DMAC7.html)
EP (1) EP1227811B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003512419A (cg-RX-API-DMAC7.html)
KR (1) KR20020060213A (cg-RX-API-DMAC7.html)
CN (1) CN1188125C (cg-RX-API-DMAC7.html)
AR (1) AR026241A1 (cg-RX-API-DMAC7.html)
AT (1) ATE257702T1 (cg-RX-API-DMAC7.html)
AU (1) AU778836B2 (cg-RX-API-DMAC7.html)
BR (1) BR0015024A (cg-RX-API-DMAC7.html)
CA (1) CA2388956A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ295925B6 (cg-RX-API-DMAC7.html)
DE (2) DE19951701A1 (cg-RX-API-DMAC7.html)
DK (1) DK1227811T3 (cg-RX-API-DMAC7.html)
EE (1) EE200200218A (cg-RX-API-DMAC7.html)
ES (1) ES2213621T3 (cg-RX-API-DMAC7.html)
HK (1) HK1048938B (cg-RX-API-DMAC7.html)
HR (1) HRP20020362A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0203213A3 (cg-RX-API-DMAC7.html)
IL (1) IL149208A0 (cg-RX-API-DMAC7.html)
NO (1) NO20021909L (cg-RX-API-DMAC7.html)
NZ (1) NZ518586A (cg-RX-API-DMAC7.html)
PL (1) PL355911A1 (cg-RX-API-DMAC7.html)
PT (1) PT1227811E (cg-RX-API-DMAC7.html)
RU (1) RU2257205C2 (cg-RX-API-DMAC7.html)
SK (1) SK5512002A3 (cg-RX-API-DMAC7.html)
TR (1) TR200201140T2 (cg-RX-API-DMAC7.html)
TW (1) TWI246424B (cg-RX-API-DMAC7.html)
WO (1) WO2001030327A2 (cg-RX-API-DMAC7.html)
YU (1) YU20902A (cg-RX-API-DMAC7.html)
ZA (1) ZA200203035B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6726829B2 (en) * 1997-04-08 2004-04-27 Scimed Life Systems, Inc. Method of manufacturing a stent
EP1465863B1 (en) * 2002-01-04 2008-07-09 NeuroSearch A/S Potassium channel modulators
AR049847A1 (es) * 2004-07-29 2006-09-06 Merck & Co Inc Inhibidores de los canales de potasio
RU2373934C1 (ru) * 2008-03-19 2009-11-27 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств
WO2015175845A1 (en) * 2014-05-15 2015-11-19 Peloton Therapeutics, Inc. Benzimidazole derivatives and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
BE794940A (fr) * 1972-02-04 1973-08-02 Gist Brocades Nv Nouveaux composes anorexigenes
US4152441A (en) 1972-02-04 1979-05-01 Gist-Brocades N.V. Analgesic imidazolemethanols
US5063220A (en) * 1988-10-21 1991-11-05 Syntex Pharmaceuticals, Ltd. Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
US6175013B1 (en) * 1994-06-10 2001-01-16 Eli Lilly And Company Imidazolinyl tachykinin receptor antagonists
JP3404749B2 (ja) 1996-06-27 2003-05-12 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ N―[4―(ヘテロアリールメチル)フェニル]―ヘテロアリールアミン

Also Published As

Publication number Publication date
SK5512002A3 (en) 2002-08-06
DK1227811T3 (da) 2004-04-19
HUP0203213A2 (en) 2003-05-28
WO2001030327A3 (de) 2002-03-14
EE200200218A (et) 2003-06-16
KR20020060213A (ko) 2002-07-16
HRP20020362A2 (en) 2004-02-29
CA2388956A1 (en) 2001-05-03
NO20021909D0 (no) 2002-04-23
HUP0203213A3 (en) 2003-07-28
CZ295925B6 (cs) 2005-11-16
RU2002113666A (ru) 2004-01-10
DE19951701A1 (de) 2001-05-03
IL149208A0 (en) 2002-11-10
HK1048938A1 (en) 2003-04-25
ZA200203035B (en) 2003-03-14
RU2257205C2 (ru) 2005-07-27
WO2001030327A2 (de) 2001-05-03
CN1188125C (zh) 2005-02-09
US6291502B1 (en) 2001-09-18
PL355911A1 (en) 2004-05-31
PT1227811E (pt) 2004-05-31
TR200201140T2 (tr) 2002-11-21
CZ20021452A3 (cs) 2002-07-17
TWI246424B (en) 2006-01-01
EP1227811B1 (de) 2004-01-14
AU778836B2 (en) 2004-12-23
ATE257702T1 (de) 2004-01-15
NO20021909L (no) 2002-04-23
DE50005040D1 (de) 2004-02-19
YU20902A (sh) 2004-11-25
AR026241A1 (es) 2003-02-05
AU1138201A (en) 2001-05-08
JP2003512419A (ja) 2003-04-02
EP1227811A2 (de) 2002-08-07
ES2213621T3 (es) 2004-09-01
NZ518586A (en) 2004-07-30
CN1373663A (zh) 2002-10-09
HK1048938B (zh) 2005-06-10

Similar Documents

Publication Publication Date Title
MEP36608A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
BR0207910A (pt) HidantÈnios e sua utilização no tratamento do diabetes
BR9915553A (pt) Amidas de ácido antranìlico e seu emprego como medicamento
BR0213522A (pt) Composto, composição farmacêutica, métodos de inibir a hiv integrase e para prevenir ou tratar a infecção pelo hiv ou para prevenir, tratar ou retardar o inìcio da aids em um paciente, e, combinação útil para tratar ou prevenir a infecção pelo hiv ou para prevenir, tratar ou retardar o inìcio da aids
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
BR0112986A (pt) Compostos azabicìclicos, o respectivo preparo e a respectiva utilização como medicamentos, notadamente como antibacteriano
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
BR0112591A (pt) Derivados de acridina e sua aplicação como medicamento
BR9611400A (pt) "agentes antimicobiano de benzoxazina".
BR0000003A (pt) Azalidas e métodos de preparação das mesmas
BR9810745A (pt) Derivados de benzimidazol
BRPI0111591B8 (pt) composto, composição farmacêutica, e, usos de um composto
BR0115045A (pt) Compostos, processo para sua preparação, composição farmacêutica que compreende os mesmos, sua utilização, processo para o tratamento e profilaxia de artrite, diabetes, distúrbios alimentares e obesidade
SE9901573D0 (sv) New compounds
BR9906373A (pt) Compostos pirimidinona, composições farmacêuticas contendo os compostos e processos para a preparação dos mesmos
BRPI0408744A (pt) 4-feniltetrahidroisoquinolinas substituìdas, processos para preparação das mesmas, seu uso como medicamento, bem como medicamento que contém as mesmas
BR0113590A (pt) 7-oxo-piridopirimidinas
BR9914929A (pt) Fenil - alquenoil - guanidinas substituìdas de ácido biliar, processos para a sua preparação, sua aplicação como medicamentos ou agentes diagnósticos, assim como medicamento contendo as mesmas
BR0111933A (pt) Uso de ácido pamÈico ou um de seus derivados, ou um de seus análogos, para a preparação de um medicamento para o tratamento de doenças caracterizadas por depósitos de agregados amilõides
BR0016360A (pt) Derivados de norbornilamino substituìdos, processos para a sua preparação, seu emprego como medicamento ou diagnóstico bem como medicamento contendo os mesmos
BR9913982A (pt) Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares
AR039895A1 (es) Composicion que comprende una vitamina, una sal de metal y una insulina o una hormona del crecimiento y uso de dichos componentes para prepararla
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
BR0214046A (pt) Derivados de pirazol como substâncias psicofarmacêuticas
BR0014233A (pt) Conjugados de 4-benzilaminoquinolina com ácido galênico e seus heteroanálogos, processos para a sua preparação, medicamentos contendo estes compostos e sua aplicação

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A E 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.